You Should Be More Freaked Out by Shingles
The viral infection leaves millions with chronic pain, increased stroke risk, and lifelong nerve damage—yet vaccination rates remain dangerously low.
The viral infection leaves millions with chronic pain, increased stroke risk, and lifelong nerve damage—yet vaccination rates remain dangerously low.
Today, I’m talking with Sarah Personette, CEO of Puck, which is a fancy new media company that’s been around for just about five years now. Puck hires big stars and gives them newsletters that are all mostly part of a…
SwitchBot is introducing a new version of the tiny button-pressing robot that helped launch the company a decade ago. The functionality of the new SwitchBot Bot is exactly the same as the original that the company will continue to sell,…
The viral infection leaves millions with chronic pain, increased stroke risk, and lifelong nerve damage—yet vaccination rates remain dangerously low.
Today, I’m talking with Sarah Personette, CEO of Puck, which is a fancy new media company that’s been around for just about five years now. Puck hires big stars and gives them newsletters that are all mostly part of a…
SwitchBot is introducing a new version of the tiny button-pressing robot that helped launch the company a decade ago. The functionality of the new SwitchBot Bot is exactly the same as the original that the company will continue to sell,…
The viral infection leaves millions with chronic pain, increased stroke risk, and lifelong nerve damage—yet vaccination rates remain dangerously low.
Today, I’m talking with Sarah Personette, CEO of Puck, which is a fancy new media company that’s been around for just about five years now. Puck hires big stars and gives them newsletters that are all mostly part of a…
SwitchBot is introducing a new version of the tiny button-pressing robot that helped launch the company a decade ago. The functionality of the new SwitchBot Bot is exactly the same as the original that the company will continue to sell,…
The viral infection leaves millions with chronic pain, increased stroke risk, and lifelong nerve damage—yet vaccination rates remain dangerously low.